BlueWillow Biologics
PrivateLast Round
Grant
Oct 1, 2019
Total Funding Raised
$84.83M
Company Overview
BlueWillow Biologics is a biotechnology company that develops intranasal vaccines and adjuvant technology to protect against infectious diseases and food allergies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Defense Tech
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BlueWillow Biologics Comparables
Compare BlueWillow Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blue Lake Biotechnology, Inc. | 82% | |
| Codagenix | 79% | |
| Altimmune Inc | 77% |
BlueWillow Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 1, 2019 | ||||
| Grant | Sep 26, 2018 | ||||
| Series A | May 7, 2018 | ||||
| Series C | Nov 28, 2012 | ||||
| Grant | Nov 30, 2010 | ||||
Series B | Jul 8, 2009 |
Key People
Founding team and executive leadership
BlueWillow Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Coast Technology Investors | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| Perseus, L.L.C. | Series B, Private Equity |
| Venture Investors LLC | Series B |
| Bill & Melinda Gates Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 577% MoM.
- Oct 1, 2019
$3.2M grant from National Institute of Allergy and Infectious Diseases.
BlueWillow Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BlueWillow Biologics's valuation, stock price, and market status.
Is BlueWillow Biologics a public or private company?
BlueWillow Biologics is a private company.
What is the current stock price of BlueWillow Biologics?
BlueWillow Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is BlueWillow Biologics worth (valuation)?
Valuation information for BlueWillow Biologics is not publicly available.
Can I buy BlueWillow Biologics stock?
BlueWillow Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BlueWillow Biologics's last funding round?
BlueWillow Biologics's most recent funding round was Grant on October 1, 2019.
Who are the main investors in BlueWillow Biologics?
Key investors in BlueWillow Biologics include North Coast Technology Investors, Perseus, L.L.C..
Will BlueWillow Biologics IPO soon?
No public IPO plans have been announced for BlueWillow Biologics.
How can I track BlueWillow Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BlueWillow Biologics's secondary market activity and sign up for updates.